Press Release
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) has begun supplying reagents to measure Aβ in the blood for Labcorp's Amyloid Beta (Aβ) LDT1. Labcorp is a global leader of innovative and comprehensive laboratory services. Utilizing samples from patients suspected of having Alzheimer's disease, this LDT assists in identifying Aβ accumulation in the brain— thought to be a leading cause of the disease.
Sysmex is actively pursuing global IVD clearances for the intended use of this reagent and continues to leverage diagnostic technologies in Japan and overseas to improve people’s lifetime healthcare journey and support healthy lives.
Terminology
1 | A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured, and used within a single laboratory. |